PROSPECTIVE MULTICENTER PROGRAM OF REMOTE CONTROL IN ANTIVITAMIN K ANTICOAGULANTS
(Abstract release date: 05/19/16)
EHA Library. Gómez Crespo M. 06/09/16; 135001; PB2101
Maria José Gómez Crespo
Contributions
Contributions
Abstract
Abstract: PB2101
Type: Publication Only
Background
The use of oral anticoagulant therapy with VKA (OAT) has progressively increased in the cardiovascular diseases, such as atrial fibrillation, valvular diseases,and venous thromboembolic disorders. The OAT is currently used in 1.7-2 % of the population. The grade of anticoagulation control is a vital aspect in the quality of clinical care of these patients. The fact that they remain above or below the optimal range exposes the patients to an increased risk of bleeding or stroke. The new technologies of information and communication allow us to optimize the control of these treatments significantly improving their quality of life and safety
Aims
1. To evaluate the efficacy and safety of remote control (RC) of OAT in a group of 100 patients.2. To analyze the degree of satisfaction and quality of life of patients included in the program.
Methods
Prospective multicenter study of the first 100 patients included in our program. The study has been carried out from June 2015 to nowadays. The institutional review board waived informed consent for this health care program that was compliant with the Spanish law in force. The participating centers are: Hospital Universitario Fundación Jiménez Díaz, Hospital Universitario Infanta Elena, Hospital Universitario Rey Juan Carlos and Hospital General de Villalba. Patients were included if meeting the following inclusion criteria: a history of use of OAT for at least three months, a valid chronic indication for the treatment and patients that were capable of handling computerized devices. The exclusion criteria were: patients under age of 16 years, patients with severe diseases or with less than 3 month of treatment with OAT and those who expressed their desire not to participate in the study. We created a reference unit of OAT composed of doctors and specialized nurses: the doctors made the prescription and gave the specific instructions to the nurses. Once they were taught, they are in charge of the active education of patients.
Results
In the first 100 patients included, there there isn’t any complication with the treatment and the preliminar results of the quality life surveys are very good.The patients were evaluated in the OAT clinics, and were included when meeting the above mentioned inclusion criteria. Once they had signed the informed consent. After work, in a remote service,we generated a note that was accesible online to the patients in the web Patient Folder. The medical note consists of the prescription. When the control was needed, patient can introduce the result of the digital INR in the same Patient Portal. This web interaction prevents unnecessary movements of the patients and/or family members. There is no separation from the center.
Conclusion
Our RC program is a new technological system that assists patients in the control of OAT from their home.The program consists in adapting new technologies to the healthcare system to gain in quality of life, with fewer complications, greater safety and comfort for patients and reducing travelling to the hospital and costs. With this program the patients are an actives subjects in the management of their disease.
Session topic: E-poster
Keyword(s): Health care, Oral anticoagulant, Quality of life
Type: Publication Only
Background
The use of oral anticoagulant therapy with VKA (OAT) has progressively increased in the cardiovascular diseases, such as atrial fibrillation, valvular diseases,and venous thromboembolic disorders. The OAT is currently used in 1.7-2 % of the population. The grade of anticoagulation control is a vital aspect in the quality of clinical care of these patients. The fact that they remain above or below the optimal range exposes the patients to an increased risk of bleeding or stroke. The new technologies of information and communication allow us to optimize the control of these treatments significantly improving their quality of life and safety
Aims
1. To evaluate the efficacy and safety of remote control (RC) of OAT in a group of 100 patients.2. To analyze the degree of satisfaction and quality of life of patients included in the program.
Methods
Prospective multicenter study of the first 100 patients included in our program. The study has been carried out from June 2015 to nowadays. The institutional review board waived informed consent for this health care program that was compliant with the Spanish law in force. The participating centers are: Hospital Universitario Fundación Jiménez Díaz, Hospital Universitario Infanta Elena, Hospital Universitario Rey Juan Carlos and Hospital General de Villalba. Patients were included if meeting the following inclusion criteria: a history of use of OAT for at least three months, a valid chronic indication for the treatment and patients that were capable of handling computerized devices. The exclusion criteria were: patients under age of 16 years, patients with severe diseases or with less than 3 month of treatment with OAT and those who expressed their desire not to participate in the study. We created a reference unit of OAT composed of doctors and specialized nurses: the doctors made the prescription and gave the specific instructions to the nurses. Once they were taught, they are in charge of the active education of patients.
Results
In the first 100 patients included, there there isn’t any complication with the treatment and the preliminar results of the quality life surveys are very good.The patients were evaluated in the OAT clinics, and were included when meeting the above mentioned inclusion criteria. Once they had signed the informed consent. After work, in a remote service,we generated a note that was accesible online to the patients in the web Patient Folder. The medical note consists of the prescription. When the control was needed, patient can introduce the result of the digital INR in the same Patient Portal. This web interaction prevents unnecessary movements of the patients and/or family members. There is no separation from the center.
Conclusion
Our RC program is a new technological system that assists patients in the control of OAT from their home.The program consists in adapting new technologies to the healthcare system to gain in quality of life, with fewer complications, greater safety and comfort for patients and reducing travelling to the hospital and costs. With this program the patients are an actives subjects in the management of their disease.
Session topic: E-poster
Keyword(s): Health care, Oral anticoagulant, Quality of life
Abstract: PB2101
Type: Publication Only
Background
The use of oral anticoagulant therapy with VKA (OAT) has progressively increased in the cardiovascular diseases, such as atrial fibrillation, valvular diseases,and venous thromboembolic disorders. The OAT is currently used in 1.7-2 % of the population. The grade of anticoagulation control is a vital aspect in the quality of clinical care of these patients. The fact that they remain above or below the optimal range exposes the patients to an increased risk of bleeding or stroke. The new technologies of information and communication allow us to optimize the control of these treatments significantly improving their quality of life and safety
Aims
1. To evaluate the efficacy and safety of remote control (RC) of OAT in a group of 100 patients.2. To analyze the degree of satisfaction and quality of life of patients included in the program.
Methods
Prospective multicenter study of the first 100 patients included in our program. The study has been carried out from June 2015 to nowadays. The institutional review board waived informed consent for this health care program that was compliant with the Spanish law in force. The participating centers are: Hospital Universitario Fundación Jiménez Díaz, Hospital Universitario Infanta Elena, Hospital Universitario Rey Juan Carlos and Hospital General de Villalba. Patients were included if meeting the following inclusion criteria: a history of use of OAT for at least three months, a valid chronic indication for the treatment and patients that were capable of handling computerized devices. The exclusion criteria were: patients under age of 16 years, patients with severe diseases or with less than 3 month of treatment with OAT and those who expressed their desire not to participate in the study. We created a reference unit of OAT composed of doctors and specialized nurses: the doctors made the prescription and gave the specific instructions to the nurses. Once they were taught, they are in charge of the active education of patients.
Results
In the first 100 patients included, there there isn’t any complication with the treatment and the preliminar results of the quality life surveys are very good.The patients were evaluated in the OAT clinics, and were included when meeting the above mentioned inclusion criteria. Once they had signed the informed consent. After work, in a remote service,we generated a note that was accesible online to the patients in the web Patient Folder. The medical note consists of the prescription. When the control was needed, patient can introduce the result of the digital INR in the same Patient Portal. This web interaction prevents unnecessary movements of the patients and/or family members. There is no separation from the center.
Conclusion
Our RC program is a new technological system that assists patients in the control of OAT from their home.The program consists in adapting new technologies to the healthcare system to gain in quality of life, with fewer complications, greater safety and comfort for patients and reducing travelling to the hospital and costs. With this program the patients are an actives subjects in the management of their disease.
Session topic: E-poster
Keyword(s): Health care, Oral anticoagulant, Quality of life
Type: Publication Only
Background
The use of oral anticoagulant therapy with VKA (OAT) has progressively increased in the cardiovascular diseases, such as atrial fibrillation, valvular diseases,and venous thromboembolic disorders. The OAT is currently used in 1.7-2 % of the population. The grade of anticoagulation control is a vital aspect in the quality of clinical care of these patients. The fact that they remain above or below the optimal range exposes the patients to an increased risk of bleeding or stroke. The new technologies of information and communication allow us to optimize the control of these treatments significantly improving their quality of life and safety
Aims
1. To evaluate the efficacy and safety of remote control (RC) of OAT in a group of 100 patients.2. To analyze the degree of satisfaction and quality of life of patients included in the program.
Methods
Prospective multicenter study of the first 100 patients included in our program. The study has been carried out from June 2015 to nowadays. The institutional review board waived informed consent for this health care program that was compliant with the Spanish law in force. The participating centers are: Hospital Universitario Fundación Jiménez Díaz, Hospital Universitario Infanta Elena, Hospital Universitario Rey Juan Carlos and Hospital General de Villalba. Patients were included if meeting the following inclusion criteria: a history of use of OAT for at least three months, a valid chronic indication for the treatment and patients that were capable of handling computerized devices. The exclusion criteria were: patients under age of 16 years, patients with severe diseases or with less than 3 month of treatment with OAT and those who expressed their desire not to participate in the study. We created a reference unit of OAT composed of doctors and specialized nurses: the doctors made the prescription and gave the specific instructions to the nurses. Once they were taught, they are in charge of the active education of patients.
Results
In the first 100 patients included, there there isn’t any complication with the treatment and the preliminar results of the quality life surveys are very good.The patients were evaluated in the OAT clinics, and were included when meeting the above mentioned inclusion criteria. Once they had signed the informed consent. After work, in a remote service,we generated a note that was accesible online to the patients in the web Patient Folder. The medical note consists of the prescription. When the control was needed, patient can introduce the result of the digital INR in the same Patient Portal. This web interaction prevents unnecessary movements of the patients and/or family members. There is no separation from the center.
Conclusion
Our RC program is a new technological system that assists patients in the control of OAT from their home.The program consists in adapting new technologies to the healthcare system to gain in quality of life, with fewer complications, greater safety and comfort for patients and reducing travelling to the hospital and costs. With this program the patients are an actives subjects in the management of their disease.
Session topic: E-poster
Keyword(s): Health care, Oral anticoagulant, Quality of life
{{ help_message }}
{{filter}}